Cash Cash Equivalents - Arcellx Inc (NASDAQ:ACLX) - Alpha Spread
A

Arcellx Inc
NASDAQ:ACLX

Watchlist Manager
Arcellx Inc
NASDAQ:ACLX
Watchlist
Price: 86.61 USD 1.38% Market Closed
Market Cap: 4.6B USD
Have any thoughts about
Arcellx Inc?
Write Note

Arcellx Inc
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Arcellx Inc
Cash & Cash Equivalents Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
A
Arcellx Inc
NASDAQ:ACLX
Cash & Cash Equivalents
$394.6m
CAGR 3-Years
104%
CAGR 5-Years
94%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash & Cash Equivalents
$13.1B
CAGR 3-Years
15%
CAGR 5-Years
20%
CAGR 10-Years
4%
Gilead Sciences Inc
NASDAQ:GILD
Cash & Cash Equivalents
$2.8B
CAGR 3-Years
-17%
CAGR 5-Years
-24%
CAGR 10-Years
-11%
Amgen Inc
NASDAQ:AMGN
Cash & Cash Equivalents
$9.3B
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
8%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash & Cash Equivalents
$4.6B
CAGR 3-Years
-9%
CAGR 5-Years
7%
CAGR 10-Years
27%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash & Cash Equivalents
$1.9B
CAGR 3-Years
-2%
CAGR 5-Years
13%
CAGR 10-Years
12%

See Also

What is Arcellx Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
394.6m USD

Based on the financial report for Dec 31, 2023, Arcellx Inc's Cash & Cash Equivalents amounts to 394.6m USD.

What is Arcellx Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
94%

Over the last year, the Cash & Cash Equivalents growth was 515%. The average annual Cash & Cash Equivalents growth rates for Arcellx Inc have been 104% over the past three years , 94% over the past five years .

Back to Top